Previous 10 | Next 10 |
2024-07-18 07:47:33 ET More on Abbott Laboratories Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price Abbott Laboratories: Why I Agree With Wall Street On This...
2024-07-18 07:31:16 ET More on Abbott Laboratories Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price Abbott Laboratories: Why I Agree With Wall Street On This One...
Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance PR Newswire Sales of $10.4 billion driven by strong underlying base business performance Reported sales growth of 4.0 percent; organic sales growth for underlying base business of 9.3 percen...
CBL International Limited (BANL) is expected to report for quarter end 2024-03-31 Hilltop Holdings Inc. (HTH) is expected to report $0.24 for Q2 2024 Avidbank Holdings Inc (AVBH) is expected to report $0.68 for Q2 2024 Community West Bancshares (New) Com (CWBC) is expected to report $...
2024-07-18 06:01:00 ET Stocks that can survive and thrive for long periods -- say, beyond 20 years -- are a special breed. These companies typically display one or several of the following characteristics: innovative abilities, leadership in a major industry, a strong moat, or exciting grow...
2024-07-17 15:16:10 ET Summary AngioDynamics stock reacted positively to fiscal Q4 results, up over 25% in a day, as the company saw 8% sequential revenue growth and 14% growth from the Med Tech portfolio. Auryon and NanoKnife generated double-digit year-over-year growth, while Al...
2024-07-17 13:14:43 ET Abbott Laboratories ( NYSE: ABT ) is scheduled to announce Q2 earnings results on Thursday, July 18th, before market open.... Read the full article on Seeking Alpha For further details see: Abbott Q2 Earnings Preview: Strong fundamentals to see...
2024-07-17 10:47:28 ET Summary Monthly article series reports aggregate industry metrics in healthcare. Healthcare providers and life science tools are moderately overvalued, while pharmaceuticals and biotechnology have the worst value and quality scores. Fidelity MSCI Health ...
2024-07-16 13:01:00 ET Short percentage in S&P 500’s healthcare companies rose slightly at the end of June from May as biotechnology industry continued to emerge as the most shorted sector, while most other sectors saw meager change in interest from last month.... Read the ...
2024-07-14 08:00:00 ET Earnings season kicks into high gear in mid-July, featuring a wave of releases from some of the world's most prominent companies. The docket includes major banks, pharmaceutical firms and airlines, as well as tech and telecom giants.... Read the full article on ...
News, Short Squeeze, Breakout and More Instantly...
Abbott, nonprofit partners build resilience in communities most impacted by natural disasters. NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Resilience. It's often defined as the ability to recover quickly from challenges and difficulties. It requires adaptability and is a skill that is esp...
2024-07-18 13:35:41 ET Abbott Laboratories (NYSE: ABT) faced a 3.0% decline in stock price this morning despite reporting a strong second quarter and raising its full-year guidance. Meanwhile, CEO Robert B. Ford thinks the overall optimism around Abbott is because of the company...
2024-07-18 09:38:21 ET The stock market is a place where investors buy and sell shares of publicly traded companies. It offers opportunities for individuals and institutions to invest in various sectors of the economy. The market’s performance is influenced by economic conditions, co...